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Introduction
 Cancer is one of the major cause of death, and primary 
and secondary prevention have been suggested for 
preventing and reducing the mortality of cancer (Adami 
et al, 2001). The Papanicolaou (Pap) test was introduced 
into cervical cancer screening in the late 1950s (Konno 
et al, 2008). With the development of mammography, the 
cancer screening test was disseminated, and randomized 
clinical trials were introduced (Andersson et al, 1988; 
Kerlikowske et al, 1995).
 Meanwhile, there was a comprehensive effort to 
develop a council-driven recommendation for the 
examination of health including cancer, and the Canadian 
Task Force on the Periodic Health Examination (CTFPHE) 
was convened in 1976 (Canadian Task Force on the 
Periodic Health Examination, 1979). A similar effort was 
initiated in the US in the 1970s (Smith et al, 2000) and the 
US Preventive Services Task Force (USPSTF) developed 
comprehensive recommendations that address preventive 
services (U.S. Preventive Services Task Force, 2002). The 
recommendation for cancer screening suggested by the 
USPSTF is predominantly opportunistic screening. 
 Operating an opportunistic or organised cancer 
screening program is a matter of the philosophy of 
health care provision or of the medical care system of 
each country (Miles et al, 2004). For decades, it has been 
proposed that organised cancer screening programmes 
can improve accessibility and promote quality and 
accountability (Hakama et al, 1985; Madlensky et al, 
2003; Miles et al, 2004). In fact, there has been a growth of 
consensus on and activities of organised cancer screening 
programmes, and several countries in Europe, Asia and 
Canada have created an action plan in an effort to improve 
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cancer screening programmes (Advisory Committee on 
Cancer Prevention, 2000; Anttila et al, 1999; Chen et al, 
2002; Hamashima et al, 2008b; Konno et al, 2008; Lee, 
2006; Miller, 2000; Smith-Bindman et al, 2003; Yeoh et 
al, 2006).
 Korea introduced mandatory social health insurance 
for industrial workers in major companies in 1977, and it 
was expanded to the entire population until 1989. Since 
2000, all public health insurance programmes have 
been merged into one single payer, the National Health 
Insurance (NHI) programme (Kwon, 2009). The Medical 
Aid program in Korea, which provides substantial medical 
services for low-income people, was initiated in 1979 after 
its promulgation of the Medical Aid Act in 1977. The 
Medical Aid programme provides beneficiaries with the 
same benefit package as that of the people insured by the 
NHI programme. Government supplies budget for Medical 
Aid programme and NHI Corporation (NHIC) which is 
responsible for operating the programme on behalf of the 
government. The NHIC reimburses providers for medical 
services provided to the Medical Aids (Yoo, 2008).
 In Korea, approximately 178,000 people are diagnosed 
with cancer annually and approximately 68,000 persons 
die from cancer (Jung et al, 2011). Cancer has been the 
leading cause of death in Korea since 1983 (National 
Statistical Office.2011). To reduce the burden of cancer 
in Korea, the Pap smear was first introduced in 1988 in 
a health examination for industrial workers. In 1999, the 
National Cancer Screening Programme (NCSP), which 
supplied Medicaid participants with stomach, breast and 
cervical cancer screening free-of-charge, was launched 
(Lee, 2006). The NCSP has been expanding benefit 
participants and target cancer sites, and now Medicaid 
recipients and those within the lower 50% of the NHIC 
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premium receive benefits for five cancer sites: the stomach, 
liver, colorectum, breast and uterine cervix. Those within 
the upper 50% of the NHIC premium who are not target 
population for the National Cancer Screening Programme, 
can receive cancer screening from the organized system 
of health screening with a 20% out-of-pocket expense. 
 
Structure and History
 Mass screening of cancer was introduced in a social 
insurance programme for a limited number of recipients 
without financial support from the government. The Pap 
smear is a free service provided in the regular health 
check-up of the industrial workers and their supported 
family members since 1988. From 1990, for government 
employees and teachers who are willing to pay 50% 
of the fee for test, cancer screening for the five sites of 
the stomach, liver, colorectum, breast and cervix was 
provided as part of a biennial health examination. The 
government employees, teachers and their dependents 
were affiliated with a distinct insurance programme by a 
single insurance society. Given that the cancer screening 
programme targeted the all-insured people, the consensus 
is that organised screening was introduced in Korea in 
1990. However, these programmes provided benefits to 
only a small number of persons. The target population 
should have been expanded, especially to include those 
with medical aid because lower social economic status is 
related to higher cancer mortality and morbidity. 
 In 1996, the Korean government initiated a 
comprehensive ‘10-year Plan for Cancer Control’ through 
2005. The aim of that period was to construct an infra-
structure to conquer cancer by building the capacity of 
cancer control and creating programmes for cancer control. 
One of the four main programmes was secondary cancer 
prevention activities and research. To build capacity, the 
Division of Cancer Control was set up within the Ministry 
for Health, Welfare and Family Affairs Bureau of Health 
in 2000. Additionally, the research building and hospital 
of the National Cancer Center, and the National Cancer 
Control Institute, was founded in 2001. 
 In 1999, with financial support from the central 
government and local government by 50% each, the 
NCSP was launched, and public health centres offered 
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free cancer screening for the stomach, breast and cervix to 
medical aid beneficiaries (Table 1). At that time, eligible 
population of medical aid beneficiaries was contacted by 
the public health centres. The target population of the 
NCSP was expanded to include NHI beneficiaries within 
the lower 20 percent income bracket in 2002, and it has 
further expanded to include those within the lower 50% 
of the NHIC premium since 2005. Medical Aids were 
supported by the government. For the lower 50% of 
NHI beneficiaries, 80% of the funds for stomach, liver, 
colorectum and breast screening were raised from the 
NHI finance, 10% from the central government, and 10% 
from the local government. For cervix screening, 100% 
was funded from the NHI finance. Since 2002, the eligible 
individuals of the NCSP are contacted by the NHIC and 
invited via a mailed letter. The NCSP is managed and 
monitored by the National Cancer Centre, in cooperation 
with the NHIC. 
 For those within the upper 50% of the NHIC premium, 
cancer screening for the stomach, liver, colorectum, breast 
and uterine cervix began in the biennial NHIC medical 
evaluation in 2001. Out-of-pocket expenses began as 50% 
of the fee for test, but were reduced to 20% in 2005. From 
2010, for the upper 50% of NHI beneficiaries, 90% of the 
funds for stomach, liver, colorectum and breast screening 
are supported from the NHI finance and 10% is paid by 
the screenees. For cervix screening, 100% is funded by 
the NHI. Cancer screening for those within the upper 50% 
of the NHIC premium is managed and monitored by the 
NHIC. 
 A legal framework for controlling cancer, The Cancer 
Control Act, was legislated in 2003. The Ministry for 
Health and Welfare was authorised to formulate and 
implement cancer control programs by this law. Based 
on the Cancer Control Act, the Ministry for Health 
and Welfare was available to conduct organised cancer 
screening more systematically by cooperating with public 
institutions.
 
Guideline development 
Although a nationwide population-based cancer screening 
program was initiated, it began as a supported programme 
of the medical service, and there were no consent 
guidelines. Two years after screening, it was recognised 
that a standardised protocol including concepts of cancer 
screening, sites of screening, screening methods and 
duration should be disseminated to local areas to prevent 
frequent screening, reduce the harm of screening and 
manage the program’s quality.
To develop guidelines for cancer screening, the National 
Cancer Screening Programme Support and Evaluation 
Council was constituted by the National Cancer Centre 
and the Ministry for Health, Welfare and Family Affairs 
in 2001 (Lee et al, 2002). The Guideline Developing 
Committee, under the National Cancer Screening 
Programme Support and Evaluation Council, consisted 
of gastroenterologists, gynaecologists, breast cancer 
surgeons, primary physicians, family medicine specialists, 
epidemiologists, and public health researchers. Health 
professionals who were representative of academic 
societies such as the Korean Gastric Cancer Association, 
Table 1. Brief History of the National Cancer 
Screening Programme in Korea 
Year Remarkable features
1996 First term of 10-Year Plan of Cancer Control was 
launched.
1999 The National Cancer Screening Programme launched 
for stomach, breast, and cervical cancer free-of-charge. 
Target population was Medical Aids.
2002 Target population expanded including the lower 20% of 
National Health Insurance beneficiaries.
2003 Liver cancer was additionally serviced and the target 
population expanded to the lower 30% of National 
Health Insurance beneficiaries.
2003 Cancer Control Act, a legal framework for controlling 
cancer in Korea, was legislated.
2004 Colon cancer screening was additionally serviced.
2005 Target population expanded to the lower 50% of National 
Health Insurance beneficiaries.
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Korean Association for the Study of the Liver, Korean 
Society of Coloproctology, and Korean Breast Cancer 
Society were included in the panel. A systematic 
review was conducted by the members of the Guideline 
Developing Committee for each of five screening sites, 
and the recommendation driven from the Guideline 
Developing Committee was evaluated by research 
groups of the academic societies for each of five cancers. 
Based on the cost-effectiveness, consideration of the 
budget, administrative capacity and capability of the 
professionals, guidelines for opportunistic and organised 
screening were produced. These guidelines modified the 
recommendations made by the academic societies and 
National Cancer Center of Korea.  
 To screen gastric cancer, a gastro-endoscopy or upper 
gastrointestinal series every 2 years is recommended 
to those aged 40 or over (Table 2). Liver cancer is 
recommended only to people aged 40 or over who are 
HBs-Antigen or anti-HCV positive or have liver cirrhosis. 
An ultrasonographic examination and α-feto-protein 
test is done every 6 months for these high risk groups. 
Colorectal cancer screening is done for those aged 50 or 
over, and the primary test is an annual faecal occult blood 
test. People with positive results from the faecal occult 
blood test can have a colonoscopy or double-contrast 
barium enema test, as well as a histological examination 
if needed. Mammography is recommended to women aged 
40 or over. A Pap smear every 2 years is recommended to 
women aged 30 or over for cervical cancer screening.
 Here, we introduce the National Cancer Screening 
Programme in Korea and describe the history of the 
development of the guidelines and the practical procedures 
of the programme. We analysed the data from the National 
Screening Programme from 2002 to 2008, which is the 
period in which the data were entered into and managed 
by a computerised system. Moreover, to highlight the 
cancer screening status in Korea, we also report the cancer 
screening rate in Korea from 2004 to 2009 using a survey 
that is representative of the population.
 
Materials and Methods
National Cancer Screening Programme 
 All of the target population receives an invitation letter 
from the NHIC at the beginning of the year (Table 3). The 
NHIC is responsible for sending the invitation letter, and 
the Public Health Centres are responsible for following-
up on the participation rate and encouraging the target 
people. The Public Health Centres encourage the public to 
receive cancer screening by campaigning and also assure 
the target people individually by telephone or letter that 
they were selected and can receive the cancer screening 
programme. 
 Clinics, hospitals, and specific screening facilities 
voluntarily apply to be certified as an institution for the 
national cancer screening programme. They are permitted 
if their equipment satisfies the required criteria. Some 
institutions have mobile vans and visit small towns that 
do not have clinics certified as a NCSP hospital. 
 Target subjects voluntarily decide whether to make 
a reservation for screening. They can visit any clinic or 
hospital that is certified as a screening unit of the NCSP. 
They visit hospitals or clinics to receive screening, fill-
out an information sheet for cancer screening, and are 
screened. After screening, their results are sent to them 
within 15 days. If someone is diagnosed with cancer or if 
there is a suspicion of cancer, he or she will be contacted 
by the public health centre for the follow-up process. Two 
years after the screened year, they will be selected as a 
target individual and may receive another invitation letter.
Screening institutions enter the results into the web-based 
database of the NHIC and are paid for their screening 
services by the NHIC. The performance of the NCSP is 
monitored by the NCC. The NCC back up our NCSP data 
with the NHIC web database every month, and the results 
of the previous year are published every year. 
 In this study, numbers of the target population, 
numbers of participants and participation rate by each type 
of cancer site of the national cancer screening programme 
in Korea from 2002 to 2008 , are presented. The numerator 
of the participation rates of the national cancer screening 
programme is the number of participants each year, and 
the denominator is the number of individuals within the 
target population each year. One person can be eligible 
for more than one site of cancer screening; therefore, we 
calculated the number of individuals within the target 
population, number of participants and participation rate 
for the ‘total’, which is the number of persons who had 
at least one site screened. 
Korea National Cancer Screening Survey
 To determine the current state of cancer screening in 
Korea, including not only organised screening but also 
individual screening, the Korea National Cancer Screening 
Survey has been conducted every year since 2004. To 
select representative people of the entire country, subjects 
are selected by a multi-stage random sampling method that 
is stratified by sex, age, and residence area, based on the 
population calculated from the National Statistical Office 
every year. 
 The inclusion criteria for the participants were 
women aged 30 or more or men aged 40 or more with no 
previous history of cancer. Participants were questioned 
about the cancer screening at several sites that are 
recommended by the NCSP guideline according to their 
Table 2. National Cancer Screening Programme 
Guidelines in Korea
Cancer     Target Pop        Freq      Test or Procedure
Stomach ≥40yrs, m&f 2 y Gastric endoscopy or 
     upper gastro-intestinal   
     series
Liver ≥40yrs1, m&f 6 m US, serum alpha-feto   
     protein 
Colo- ≥50yrs, m&f Yearly Faecal occult blood test, 
 rectum     if positive then colonoscopy
     or double-contrast barium  
     enema 
Breast ≥40yrs, f 2 y Mammography± clinical  
     breast examination
Cervix ≥30yrs, f 2 y Pap smear 
1with HBsAg positive or anti-HCV positive results or liver 
cirrhosis
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age. Questions pertaining to methods, duration, payment 
system (organised or individual) for screening, and plans 
for future screening were asked. Data on socioeconomic 
factors including education level, income and marital 
status were collected. A history of chronic diseases, 
subjective health status, and history of familial cancer 
were reported. Information on health behaviours including 
smoking status, alcohol intake, vaccination history, 
physical activity, and regular health-exam history was also 
gathered. We interviewed more than 2,000 persons every 
year: 3,592 in 2004, 2,028 in 2005, 2,030 in 2006, 2,021 
in 2007, 2,038 in 2008 and 2,000 in 2009. We conducted 
telephone surveys in 2004 and face-to-face interviews 
from 2005 to 2009.
 We calculated ‘Cancer screening rates with 
recommendation’ for five types of cancer. This is defined 
as the proportion of people that followed the cancer 
screening guideline in the nearest years (Table 2), such 
as the proportion of people who have received a gastric 
endoscopy or upper gastro-intestinal series in the latest two 
years among males and females aged 40 or more (in line 
with the recommendation for stomach cancer), proportion 
of females who have received a mammographic test in the 
latest two years among those aged 40 or more (in line with 
the recommendation for breast cancer), and proportion of 
females aged 30 and above who have received a Pap smear 
in the latest two years (in line with the recommendation 
for cervical cancer). For colorectal cancer, the national 
cancer screening guideline recommends the faecal 
occult blood test as the first choice, and if this shows 
positive results, a further exam with colonoscopy or 
double-contrast barium enema is recommended. From the 
‘Cancer screening guideline for five common cancers’, 
colonoscopy is recommended every 10 years or barium 
enema is recommended every 5 years. Here we present 
colorectal cancer screening rates using both definitions. 
Liver cancer screening is suggested every 6 months for 
high risk groups, which are those aged 40 or over with 
HBsAg or anti-HCV positive results or liver cirrhosis.
 
Results 
National Cancer Screening Programme in Korea, 2002-
2008 
The number of individuals within the target population 
and participants increased for all screening sites during the 
2002 to 2008 period (Table 4). The target population for 
five sites was more than 6 million in 2002, and increased 
to more than 16 million in 2008. Participation rate also 
increased from 12.7% in 2002 to 27.8% in 2008. The 
participation rate for stomach cancer was 11.4% in 2002, 
and increased to 29.2% in 2008. For breast cancer, the 
participation rate was 14.1% in 2002 and 37.9% in 2008; 
Table 4. Number of Individuals within Target Population and Participation Rate of National Cancer Screening 
Programme in Korea, 2002-2008
Cancer site Variable Year               2002    2003         2004              2005     2006           2007  2008
Stomach No. target 3,516,889 4,219,332 3,689,401 5,735,863 7,029,289 6,812,344 7,132,820
  No. actual 402,204 575,124 578,830 1,150,007 1,531,360 1,727,910 2,085,978
  PR1 % 11.4 13.6 15.7 20.0 21.8 25.4 29.2
Liver2 No. target  271,501 175,073 393,737 455,308 456,634 433,822
  No. actual  42,990 41,918 102,394 118,414 130,531 141,852
  PR %  15.8 23.9 26 26 28.6 32.7
Colorectum No. target   2,266,656 3,474,440 4,406,826 4,344,969 4,640,365
  No. actual   239,047 536,399 696,445 785,919 984,957
  PR %   10.5 15.4 15.8 18.1 21.2
Breast No. target  1,992,724 2,315,786 1,922,488 3,022,115 3,587,692 3,531,629 3,706,062
  No. actual 279,985 385,994 357,122 728,556 948,495 1,066,882 1,295,152
  PR % 14.1 16.7 18.6 24.1 26.4 30.2 34.9
Cervix No. target 583,494 575,243 554,991 577,531 599,434 640,642 647,630
  No. actual 89,916 61,223 55,004 71,312 70,624 80,657 90,029
  PR % 15.4 10.6 9.9 12.3 11.8 12.6 13.9
Total No. target 6,093,107 7,381,862 8,608,609 13,203,686 16,078,549 15,786,218 16,560,699
  No. actual 772,105 1,065,331 1,271,921 2,588,668 3,365,338 3,791,899 4,597,968
  PR % 12.7 14.4 14.8 19.6 20.9 24.0 27.8
1Participation rates are defined as number of participants divided by number within target population; 2Number of individuals 
within target population includes participants of high risk group (Age 40 & over with HBsAg positive or anti-HCV positive results 
or liver cirrhosis) and people who are not aware of their antibody status among the Social Aids
Table 3. Process of the National Cancer Screening 
Programme in Korea in a Year
 Steps
1. Target population selected by the National Health 
Insurance Cooperation and the National Cancer Centre 
at the beginning of the year
2. Invitation letters sent to selected people from the 
National Health Insurance Cooperation; Public health 
centres monitoring the procedure and receiving inquiries 
or questions from public
3. Subjects visit hospitals or clinics to receive cancer 
screening throughout the year
4. Test results sent to screened people within 15 days, and 
results entered into the Web Database of the National 
Health Insurance Cooperation within 30 days after the 
test by the hospitals or clinics
5. Hospitals or clinics send bills to the National Health 
Insurance Cooperation to claim the fee for test
6. Non-recipients encouraged to participate by public 
health centres in the third and fourth quarter of the year
7. The programme monitored by the National Cancer 
Centre throughout the year
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therefore, the percent point increase between 2002 and 
2008 was 20.8%, which was the highest among the five 
sites. Liver cancer screening for high risk groups began 
in 2003. The participation rate for this screening was 
15.8% in 2002, but grew to 32.7% in 2008. Colorectal 
cancer screening, which began in 2004 showed the lowest 
participation rate in its first year (10.5%); however, it 
increased to 21.2% in 2008. The cervical cancer screening 
rate in NCSP includes only the medical aid people, and 
the target population and participation numbers are much 
lower than breast screening. Cervical cancer screening 
shows the lowest rates, which were 12.7% in 2002 and 
27.8% in 2008.
Korea National Cancer Screening Survey, 2004-2009 
The age-adjusted cancer screening rate with 
recommendations was 38.8% in 2004 and 53.3% in 2009, 
as calculated from the Korea National Cancer Screening 
Survey (Table 5). The cancer screening rate of stomach 
cancer was 56.9%, of the breast was 55.2%, and of the 
cervix was 63.9% in 2009. Liver cancer screening rate 
among high risk groups (those aged more than 40 years 
with HBsAg positive or anti-HCV positive results or liver 
cirrhosis) was 31.3% in 2009. Colorectal cancer screening 
rate with any test including colonoscopy, barium enema 
and faecal occult blood test was 36.7%. The stomach, 
liver, breast and cervical cancer screening rates increased 
over five years; however, colorectal cancer screening did 
not show this trend. 
Discussion
An overview of the organised cancer screening 
programme in Korea and description of the National 
Cancer Screening Programme are presented in this 
study, including the volume outcome from 2002 to 2008. 
Moreover, to highlights the cancer screening status in 
Korea, we described the results of the Korea National 
Cancer Screening Survey from 2004 to 2009.
Organised cancer screening began as a government-
driven policy as a public welfare to medical aids. In 
the beginning, the system was not well structured and 
no standardised recommendations or guidelines were 
suggested. It was stably set up and expanded stably by 
the legal legislation, by a financial support from the 
national health insurance system and by the activities 
of working groups of professionals that were driven by 
the National Cancer Screening Program Support and 
Evaluation Council. To plant a successful evidence-
based cancer control policy, it is essential to conduct a 
systematic review. Japan had a cancer screening guideline 
since 2001, which was suggested by a non-systematic 
and non-standardized reviewed research (Hamashima et 
al, 2008a). Recently they re-established a standardized 
guideline development process on cancer screening, and 
based on this method, colorectal, gastric and lung cancer 
screening in Japan was revised (Hamashima et al, 2008a). 
The administration system or health insurance system 
determines introduction and success of organised cancer 
screening. Korean has resident registration number which 
is an identical social number, and every administrative, 
medical and social services in Korea are performed based 
on this ID number. Every steps of performance of NCSP is 
managed by resident registration number; invitation letter 
is sent by extracting contact information from ID number, 
information of register in clinic, results of screening are 
managed by ID number through the NHIC database. 
National insurance system also contributed to the rapid 
stabilization and high efficiency of the NCSP.
After ten years of managing the organised cancer 
screening programme, we had several achievements. 
First, the programme covers the entire population with 
few personal expenses, and the number of people who 
receive cancer screening has increased. Participation 
rate of the organised cancer screening increased as well 
as cancer screening rate with recommendation including 
private screening has been increased. From the Korea 
National Cancer Screening Survey 2004-2009, proportion 
of people who used organised cancer screening not private 
screening increased from 45.7% in 2004 to 65.1% in 
2009. In the NCSP, participation rate of low income 
people has been improved, but, cancer screening rate in 
high income people has also been increased. Although the 
total volume of screened people are increased, consistent 
effort on recruiting low income people to cancer screening 
is warranted to reduce the health inequality in cancer 
survival and mortality due to social economic status. 
Second, along with the advances of medical techniques 
and increased amount of advertisement of secondary 
prevention of cancer, concerns about early detection of 
cancer have increased. The increase in participation rate 
of the NCSP and increase in cancer screening rates with 
recommendations from the survey provides evidence. 
However, compared to participation rate of National 
Health Service Cancer Screening Program in United 
Kingdom, which is 73.8% in breast screening and 80.3% 
in cervix screening in 2008, we need much improvement.
The organised cancer screening program in Korea 
has many challenges. First, this programme was not 
initiated based on evidences revealed from our own 
country, but was based on the research or suggestions 
from other countries, mainly European countries and 
Table 5.  Results of the Korea National Cancer 
Screening Survey, 2004-2009
Cancer type                          Cancer screening rates (%)
 2004     2005   2006      2007      2008     2009
Stomach 39.2 39.4 43.3 45.6 53.5 56.9
Liver1 20.0 16.3 16.5 22.7 19.7 31.3
Colorectum2 16.8 18.2 19.2 20.1 24.3 25.1
    FOBT3 3.8 7.2 13.6 23.3 20.9 19.0
    Any test4 19.9 25.4 29.4 34.1 37.9 36.7
Breast5 33.2 38.4 40.6 45.8 49.3 55.2
Cervix 58.3 57.0 54.9 57.0 59.9 63.9
Average6 38.8 40.3 42.3 45.6 50.7 53.3
1High risk group, Age 40 & over with HBsAg positive or anti-
HCV positive results or liver cirrhosis; 2Colonoscopy every 10 
years or barium enema every 5 years, which is followed by 
Cancer screening guidelines for five common cancers; 3Faecal 
occult blood test every year, which is followed by the National 
Cancer screening guidelines; 4Any test including colonoscopy, 
barium enema or faecal occult blood test; 5Mammography; 
6age-adjusted
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northern America. We must produce evidences of cancer 
screening, even in the absence of a randomised clinical 
trial. With these efforts, we may review the frequency of 
screening and ages at which screening should begin and 
end. We just started to evaluate the effectiveness of the 
screening programme through measurement indicators 
such as cancer detection rates, interval cancer rates and 
comparison of five-year survival rates or mortality rates 
before and after the screening program began. These 
parameters should be calculated using the Korea Central 
Cancer Registry data as a gold standard of diagnosis of 
cancer. 
Second, evaluating and improving the quality of 
screening is also needed. In this regard, Committee for 
Quality Assurance for each types of cancer screened 
have published a quality guideline for five types of 
cancer screening in 2008, which was revised in 2009. 
Additionally, increasing emphasis on quality assessment 
in screening should be followed. The structure and several 
performance indicators of the general hospitals and 
hospitals participating in the organised cancer screening 
programme have been evaluated since 2008. The third 
challenge is to modify the pitfalls in the management of 
the people with abnormal findings. We must reinforce 
the check-up system of referral for the people for whom 
there is a suspicion of cancer. The fourth challenge is to 
increase the screening rate. We need an individualised 
strategy to satisfy the detailed needs of each person. The 
fifth challenge is to assess the cost-effectiveness and to 
produce an evidence to improve our policy efficiently.
In summary, the National Cancer Screening Programme 
in Korea has been performed for 10 years (beginning in 
1999), and the participation rate has increased. The 
cancer screening rates for five sites have also increased 
in Korea. Equality of access may have been increased, 
and cost of screening as a barrier may have been reduced. 
Infrastructure, resourced, public awareness is considered 
to be progressed. However, we face big challenges related 
to quality, adequacy of call-recall system, high risk group 
management and still low participation rate. We have great 
potential ability to reduce cancer incidence and mortality 
by this organised cancer screening system, which may 
balance in benefit and harm. In the near future, results of 
performance measurement and outcome measurement will 
be reported. Also, we expect to produce a combined result 
of the organised cancer screening programme including 
both NHIC data and NCSP data in Korea. 
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